Searched for
HYPERTRIGLYCERIDEMIA
7 canned foods that fight high triglycerides — top picks dietitians swear byBest canned foods for heart health: Maintaining healthy triglyceride levels is crucial for heart health, and incorporating certain canned f...- Zydus Lifesciences gets USFDA nod for generic cholesterol lowering drugZydus Lifesciences Ltd. has secured final USFDA approval to manufacture generic Niacin extended-release tablets in 500 mg, 750 mg, and 1,00...
- Lupin, Zydus Lifesciences ink licensing, supply pact for Saroglitazar MgLupin and Zydus Lifesciences entered into a licensing and supply agreement to co-market Saroglitazar Mg, an innovative drug approved by Ind...
- Dr Reddy's Laboratories launches Icosapent Ethyl Capsules in USIcosapent Ethyl Capsules, used to reduce triglyceride levels in adult patients have been launched by Dr. Reddy's Laboratories in the US mar...
- Zydus Cadila receives DCGI nod for NAFLD drug Saroglitazar Mg in IndiaNon-Alcoholic Fatty Liver Disease (NAFLD) is a progressive disease of the liver, which starts with fat accumulation in the liver in patient...
- Zydus Cadila gets DCGI nod for world's first drug to treat liver diseaseThe Ahmedabad-based company said the approved product is the first ever drug anywhere in the world for treatment of Non-Cirrhotic Non-Alcoh...
- Zydus Cadila files NDA for Saroglitazar MagnesiumNASH is a progressive disease of the liver and a significant unmet medical need. There are currently no treatments available for the treatm...
- Zydus gets regulatory nod to market Lipaglyn in MexicoThe company has been granted marketing approval from the Mexican regulatory authority COFEPRIS to commercialise Lipaglyn in Mexico, Zydus s...
- Alembic Pharma's cholesterol drug gets US FDA nodThe approved product is therapeutically equivalent to the reference listed drug product Trilipix Delayed-Release capsules of Abbvie Inc.
- US FDA pulls up Cadila for misbranding drugThe company has been researching on the drug to treat fatty liver disease or non-alcoholic steatohepatitis apart from diabetic dyslipidemia.
- Cadila Healthcare misbranded Saroglitazar, says US FDAIn a December 21 letter to the company, the US FDA has said the “broad statements” made by the company as the “world’s first” is misleading...
- Zydus launches Tenglyn tablets in Indian marketDrug firm Zydus Cadila has launched its generic Tenglyn tablets belonging to new class of oral anti-diabetic treatment drugs, Gliptins, in ...
- Zydus gets USFDA nod for clinical trials of Sarolitazar"USFDA has endorsed company's plan to initiate a phase II clinical trial of Saroglitazar in patients with severe hypertriglyceridemia," Zyd...
- Ranbaxy Laboratories gets USFDA nod to sell cholesterol medicineRanbaxy received approval from USFDA to manufacture & market Fenofibrate capsules used for lowering high cholesterol & triglyceride levels ...
- Amarin Pharma files patent infringement case against Dr Reddy's Laboratories on lipid lowering drug, VascepaAmarin Pharma has filed a patent case against Dr Reddy's Labs alleging that the latter is attempting to come out with generic versions of V...
- Lupin launches generic Fenofibric Acid capsules in US marketLupin said its US arm has launched generic Fenofibric Acid capsules used for reducing cholesterol and fatty acids in the blood in the Ameri...
- Lupin launches generic Tricor in the USLupin has launched generic version of Tricor in the US market after getting approval from the US Food and Drug Administration.
Load More
